The prices of cryptos may be struggling to get back to their peaks of 2017 but that has not stopped developments in the underlying blockchain technology. In recent years, many projects and start-ups have come up and successfully integrated blockchain in their daily operations. One such startup is Nebula Genomics.
Nebula Genomics announced that it is launching DNA sequencing that will use blockchain. The new platform will eliminate the need for the customers to reveal their personal information. Hence, anyone can get to know some DNA information anonymously.
According to a post published on September 19, Nebula has already unveiled anonymous genetic testing. The tests have let customers purchase whole-genome sequencing and provided their saliva samples. They have done all that without requiring sharing their data like address, name, or even credit card number.
Eliminating Data De-Identification Dependence
To achieve this anonymity, Nebula created and implemented a blockchain-based product that allows transparent and controllable data sharing. It also offers the users an option to carry out pseudo-anonymous payments using virtual currencies. For the customers who do not have or do not intend to use digital currency, the company now recommends using a prepaid credit card to ensure that their privacy is protected.
The post read:
“Most importantly, enabling individuals to remain anonymous would eliminate the dependence on data de-identification by personal genomics companies prior to data sharing with researchers.”
In that context, Nebula confirmed that it offers anonymous sample collection services by delivering saliva collection kits to USPS PO boxes. Nebula partnered with EMD Serono in June 2019. EMD is a North American biopharmaceutical business owned by Merck KGaA. It ranks as the world’s oldest pharmaceutical firm that is still in operation.
Through its partnership with EMD Serono, Nebula plans to offer the firm with access to its network of anonymized genomic data to support the research and development of new medicines. During the announcement in June, Nebula also highlighted that its agreement with EMD Serono was the first attempt to create a model of sponsored genome sequencing.
Increasing Blockchain Adoption in the Health Sector
Earlier this month, blockchain network Harmony partnered with a Lithuanian blockchain-powered health app firm Lympo. That partnership was meant to enable fast and secure health data sharing. Lympo is currently developing an incentivizing platform for the many healthy lifestyle activities that include running and walking. It aims to boost the platform’s scalability.
According to Global Market Insights, the worth of blockchain investment in the healthcare market is anticipated to surge past $1.6 billion by 2025. This increasing investment will arise due to several factors. These factors include the implementation of various government initiatives and ever-increasing investment in the field.